UT launches Knoxville Quantum Accelerator to advance Tennessee’s future
Business Announcement
Updates every hour. Last Updated: 30-May-2026 03:15 ET (30-May-2026 07:15 GMT/UTC)
The University of Tennessee, Knoxville, is launching the Knoxville Quantum Accelerator, also known as K-Quantum, to advance the region’s position as a leader in quantum technologies and systems. Unlike the digital computing systems we rely on today, quantum systems use elements of quantum mechanics — the complex behavior of atoms and subatomic particles — to process vast amounts of information quickly and in new ways. Leveraging those properties enables breakthroughs in applications ranging from drug discovery and advanced manufacturing to cryptography and optimization.
Consumers’ around-the-clock, often impulsive demand for cheap, rapidly delivered products creates harsher working conditions in e-commerce fulfillment centers than in traditional warehouses, according to Cornell University-led research that provides the first comprehensive assessment of e-commerce work in the U.S.
Transition to electric vehicles in Brazil and Mexico has been driven by domestic politics and global pressures, a new study says.
Insilico Medicine will present its latest advances in generative AI-driven drug discovery, quantum-enabled research, and clinical development at the BIO 2026 International Convention in San Diego. The company will participate in three featured speaking sessions covering China’s impact on biotech business development, quantum computing in drug discovery, and strategies for building smarter pipelines for challenging targets. Insilico will also showcase its Pharma.AI platform, LifeStar 2 laboratory, and MMAI Gym for Science while meeting with biopharma partners, investors, and researchers at Booth #4021.
Insilico highlighted progress across its growing pipeline, including Rentosertib, the world’s first AI-discovered anti-fibrotic candidate with a novel mechanism of action, which has completed a Phase 2a proof-of-concept trial. The company also shared updates on ISM5411 for inflammatory bowel disease and multiple oncology programs that have reached first-in-patient dosing. Since its founding in 2014, Insilico has published more than 200 peer-reviewed papers and was recently recognized among the top global corporate research institutions in Nature Index rankings.
Commercial marketing oriented toward sustainability is not compatible with degrowth, even when it promotes consuming less. That is the conclusion of a study by the Institute of Environmental Science and Technology of the Universitat Autònoma de Barcelona (ICTA-UAB), Spain, and the London School of Economics and Political Science.